Lexicon Pharmaceuticals, Inc. (LXRX)

Lexicon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	34.55	22.47	46.35	64.07	126.26	36.11
Short-Term Investments	223.82	147.56	92.01	22.68	26.01	235.55
Cash & Short-Term Investments	258.37	170.03	138.36	86.74	152.28	271.66
Cash Growth	18.29%	22.89%	59.50%	-43.04%	-43.95%	69.73%
Receivables	2.9	1.01	0.03	0.01	0.4	56.53
Inventory	0.64	0.38	-	-	-	4.24
Prepaid Expenses	6.71	5.13	2.48	2.16	5.05	5.32
Total Current Assets	268.61	176.55	140.87	88.92	157.72	337.75
Property, Plant & Equipment	7.15	7.51	8.48	3.45	1.53	15.7
Goodwill	44.54	44.54	44.54	44.54	44.54	44.54
Other Intangible Assets	-	-	-	-	-	19.72
Other Long-Term Assets	0.83	0.83	0.41	-	-	-
Total Assets	321.12	229.43	194.3	136.91	203.79	417.72
Accounts Payable	14.2	14.39	10.4	9.15	5.47	12.18
Accrued Expenses	20.54	15.87	11.49	11.88	29.14	41.6
Current Portion of Long-Term Debt	-	-	-	-	11.65	11.01
Current Portion of Leases	1.3	1.29	1.29	1.09	0.55	0.55
Total Current Liabilities	36.05	31.55	23.17	22.12	46.81	65.34
Long-Term Debt	99.9	99.51	48.58	-	-	234.17
Long-Term Leases	4.68	5.27	5.42	1.19	0.61	1.1
Other Long-Term Liabilities	1.99	-	-	-	-	-
Total Liabilities	142.61	136.32	77.18	23.31	47.42	300.61
Common Stock	0.36	0.25	0.19	0.15	0.14	0.11
Additional Paid-In Capital	2,116	1,863	1,709	1,609	1,561	1,462
Retained Earnings	-1,933	-1,767	-1,590	-1,488	-1,400	-1,341
Treasury Stock	-4.62	-2.89	-2.06	-7.52	-4.84	-3.82
Comprehensive Income & Other	0.35	0.03	-0.43	-0.01	-0.01	0.08
Shareholders' Equity	178.51	93.11	117.12	113.6	156.37	117.1
Total Liabilities & Equity	321.12	229.43	194.3	136.91	203.79	417.72
Total Debt	105.87	106.06	55.29	2.28	12.81	246.84
Net Cash (Debt)	152.5	63.96	83.06	84.46	139.47	24.82
Net Cash Growth	35.64%	-23.00%	-1.66%	-39.44%	461.88%	-
Net Cash Per Share	0.52	0.29	0.50	0.58	1.26	0.21
Filing Date Shares Outstanding	361.49	246.24	188.73	149.59	143.56	106.5
Total Common Shares Outstanding	361.49	244.92	188.73	148.92	141.5	106.27
Working Capital	232.56	145	117.69	66.8	110.91	272.41
Book Value Per Share	0.49	0.38	0.62	0.76	1.11	1.10
Tangible Book Value	133.97	48.57	72.58	69.05	111.83	52.84
Tangible Book Value Per Share	0.37	0.20	0.38	0.46	0.79	0.50
Land	-	-	-	-	-	2.66
Buildings	-	-	-	-	-	59.21
Machinery	1.92	4.35	4	4.72	5.69	13.5
Leasehold Improvements	2.18	2.18	2.05	1.31	0.42	0.42

Source: S&P Capital IQ. Standard template. Financial Sources.